Actos Caused Consumer's Bladder Cancer, Philly Jury Hears

By Matt Fair (January 14, 2015, 5:20 PM EST) -- A Philadelphia jury heard opening arguments on Wednesday in a case against Takeda Pharmaceutical Co., the latest in a string of suits against the drugmaker, alleging that a retired high-school teacher developed bladder cancer after taking the diabetes drug Actos.

Miller Firm LLC attorney Michael Miller told the jury that warnings issued beginning in June 2011 about the risks associated with Actos had come too late for his client, John Kristufek, who was diagnosed with bladder cancer in December 2008.

"Actos causes bladder cancer, and the company now warns doctors that Actos could cause bladder cancer," Miller said. "We're here today...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!